Researchers from Helmholtz Munich and the Technical University of Munich (TUM) have developed "fast-RSOM," a new imaging ...
Nonpharmacologic heart failure management and interventions can reduce cardiovascular risk factors and carotid intima-media ...
Clinical Trials Arena on MSN
CVRx’s stock up as heart failure device to be trialled in expanded patient group
The device gained approval in the US in 2019 and received CE marking for use in the EU in 2014.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results